Cart
sales@molnova.com
Deschloroclozapine
CAS No. 1977-07-7
Deschloroclozapine( —— )
Catalog No. M26171 CAS No. 1977-07-7
Deschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 63 | In Stock |
|
| 5MG | 45 | In Stock |
|
| 10MG | 72 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 260 | In Stock |
|
| 100MG | 404 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDeschloroclozapine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDeschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist.
-
DescriptionDeschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist. Deschloroclozapine binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABAA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1977-07-7
-
Formula Weight292.386
-
Molecular FormulaC18H20N4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (342.02 mM)
-
SMILESCN1CCN(CC1)C1=Nc2ccccc2Nc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ali Y Benkherouf, et al. Hops Compounds Modulatory Effects and 6-prenylnaringenin Dual Mode of Action on GABA AReceptors. Eur J Pharmacol. 2020 Apr 15;873:172962.
molnova catalog
related products
-
2-Aminoacridone
2-Aminoacridone is a widely used fluorophore (λexc=428 nm, λem=525 nm).
-
Androstan-17-ol 23-e...
Androstan-17-ol 23-epithio-17-methyl- (2a3a5a17b)- is a chemical compound.
-
Metastin (human)
Potent endogenous ligand of the kisspeptin receptor (KISS1, GPR54). Binds with high affinity to rat and human KISS1 receptors with Ki values of 1.80 and 1.45 nM respectively. Inhibits chemotaxis, invasion and metastasis of human melanomas and breast carcinomas. Stimulates gonadotropin secretion following i.c.v. administration.
